# Wolf O. Bechstein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wolf-o-bechstein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,819 |
| Field | Organ Transplantation Techniques and Outcomes |
| h-index | 82 |
| i10-index | 411 |
| Last Known Institution | Goethe University Frankfurt |
| OpenAlex ID | https://openalex.org/A5039545176 |
| ORCID iD | https://orcid.org/0000-0002-3267-8145 |
| Works | 1,115 |

## Researcher papers

- [Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial](https://scholariq.org/papers/tumour-response-and-secondary-resectability-of-colorectal-liver-metastases/)
- [Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial](https://scholariq.org/papers/histopathological-regression-after-neoadjuvant-docetaxel-oxaliplatin/)
- [Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12](https://scholariq.org/papers/randomized-phase-ii-trial-of-chemoradiotherapy-plus-induction-or-consolidation/)
- [Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma](https://scholariq.org/papers/sirolimus-use-in-liver-transplant-recipients-with-hepatocellular-carcinoma/)
- [Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer](https://scholariq.org/papers/chemoradiotherapy-plus-induction-or-consolidation-chemotherapy-as-total/)
- [Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer](https://scholariq.org/papers/neoadjuvant-chemoradiation-therapy-with-gemcitabine-cisplatin-and-surgery-versus/)
- [Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients](https://scholariq.org/papers/practical-recommendations-for-long-term-management-of-modifiable-risks-in-kidney/)
- [A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma](https://scholariq.org/papers/a-prospective-randomised-open-labeled-trial-comparing-sirolimus-containing/)

## Researcher topics

- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [Goethe University Frankfurt](https://scholariq.org/institutions/goethe-university-frankfurt/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.